Judge Dismisses Claims Asserted by Proposed Economic Injury Class of OxyContin Plaintiffs

WASHINGTON - A complaint filed by two plaintiffs seeking to represent a proposed class of District of Columbia residents who sustained economic injuries was dismissed by a federal judge who ruled that the proposed class members did not suffer an injury-in-fact. Robert Williams, et al. v. The Purdue Pharma Co., et al. No. 02-0556 (RMC) (D.D.C.).

In an order docketed Dec. 31, 2003, U.S. District Judge Rosemary M. Collyer opined that the plaintiffs did not suffer an injury as a result of the alleged deceptive advertising implemented by manufacturer Purdue Pharma and Abbott Laboratories, the company that helped market OxyContin. …